Saris
Chris Saris, Newbury Park, CA US
Patent application number | Description | Published |
---|---|---|
20080241154 | Isolation, Identification and Characterization of tmst2, a Novel Member of the TNF-Receptor Supergene Family - Novel TNF receptor polypeptides are disclosed, along with polynucleotides encoding the polypeptides and uses thereof. | 10-02-2008 |
20130084290 | Antibodies to Thymic Stromal Lymphopoietin (TSLP) Receptor Molecules and Uses Thereof - The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides. | 04-04-2013 |
Christiaan J.m. Saris, Newbury Park, CA US
Patent application number | Description | Published |
---|---|---|
20110165580 | Response Element Regions - Response element regions, DNA constructs comprising response element regions, host cells comprising response element regions, and methods of using response element regions are provided. | 07-07-2011 |
Christiaan M. Saris, Newbury Park, CA US
Patent application number | Description | Published |
---|---|---|
20110305705 | ANTIBODIES TO THYMIC STROMAL LYMPHOPOIETIN RECEPTOR MOLECULES AND USES THEREOF - The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides. | 12-15-2011 |
20140273089 | Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof - The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The inventio further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides. | 09-18-2014 |
Ossian Saris, Espoo FI
Patent application number | Description | Published |
---|---|---|
20130338928 | METHODS AND SYSTEMS FOR HIGH RESOLUTION MELT ANALYSIS OF A NUCLEIC ACID SEQUENCE - Described herein are methods and systems for analyzing and visualizing HRM data from a double-stranded nucleic acid. The HRM data is generally characterized by a plurality of data points each including a signal value associated with the concentration of a double-stranded nucleic acid in a sample and a temperature value associated with a the temperature of the sample. Embodiments of the invention analyze the HRM curves from samples using the first negative derivative of the HRM curve or a virtual standard. The first negative derivative plot method may be used to identify the melting temperature of a homogenous double-stranded nucleic acid in a sample, as well as the presence and melting temperature of heterogeneous double-stranded nucleic acids in the sample. Data points associated with the melting temperature are plotted on a scatter plot for analysis. The virtual standard allows for visualization of HRM data across data sets. | 12-19-2013 |
Patrick Saris, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20150236279 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES - A compound having a structure of Formula M(L | 08-20-2015 |
Wilhelmus Hermanus Maria Saris, Meerssen NL
Patent application number | Description | Published |
---|---|---|
20110217380 | PROTEINS THAT STIMULATE THE SECRETION OF SATIETY HORMONES - The invention is in the field of weight management, in particular in the field of weight management by influencing the mechanisms of body-weight regulation. Intact pea protein and intact wheat protein were found to be effective in reducing appetite or inducing or increasing satiety when brought into contact with their receptors in the duodenum. Since it is known that intact proteins hydrolyse in the gastrointestinal tract, intact pea protein and intact wheat protein will not exhibit their satiating effect when ingested in a conventional oral preparation. Therefore, special care should be taken to deliver the intact proteins to the duodenum in order for them to arrive there intact. One object of the invention may therefore be achieved by incorporating the intact protein in an enteric delivery vehicle. | 09-08-2011 |